Analysis of clinical characteristics of 153 cases with acute myocardial infarction in Zepu County of Xinjiang Uygur Autonomous Region / 中国基层医药

ABSTRACT

Objective To analyze the clinical characteristics of patients with acute myocardial infarction (AMI) in Zepu county of Xinjiang Uygur Autonomous Region.Methods From February 2013 to January 2017,153 AMI patients hospitalized in emergency ICU of People''s Hospital of Zepu County of Xinjiang Uygur Autonomous Region were collected.The population characteristics,clinical manifestations,laboratory examinations,prognosis and complications were retrospectively analyzed and summarized.ResultsThe average age of AMI patients was 57.1 years old,included 133 cases (86.9％) ST-segment elevation myocardial infarction (STEMI),non ST elevation myocardial infarction (NSTEMI) patients were 20 cases (13.1％),most patients with chest pain (92.8％) and chest congestion(85.6％) symptoms.Anterior wall STEMI patients were 45 cases (33.8％),inferior wall infarction were 27 cases (20.3％),anteroseptal infarction were 15 cases (11.3％).73 patients were treated with thrombolysis,the recanalization rate was 93.2％.The cardiogenic shock complication occurred in 12 cases (7.8％) during hospitalization,12 cases (7.8％) were concurrent with Killip level 3 or higher heart failure,10 cases (6.5％) were concurrent with ventricular fibrillation.The onset age between Han nationality and Uygur nationality patients was significantly different (t=6.82),the onset age of Uygur nationality was younger than the Han nationality.There were no statistically significant differences between the two groups in sex,blood sugar level,cholesterol level,triglyceride level,high density lipoprotein level,low density lipoprotein level (χ2=0.02,P＞0.05;t=0.86,0.65,1.14,0.23,0.27,all P＞0.05).Conclusion The population features,clinical manifestations,disease courses and therapeutic effects of the AMI patients in Zepu county of Xinjiang Uygur Autonomous Region have certain characteristics,understanding these characteristics is beneficial for treating the disease.